Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies disclosed an opening position of 5,586,024 cash-settled derivatives in Bodycote, representing 3.28% economic exposure as at 30-10-2026, with 0% direct share ownership and no stock-settled derivatives or subscription rights. Disclosed equity-swap trades show incremental decreases and increases in the long position executed at prices between GBp 912.00 and GBp 916.00. No indemnities, voting arrangements or other agreements were declared, indicating economic exposure without declared voting control.

Disclaimer*

Companies

Bodycote (BOY)
UK 100

Latest directors dealings